🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

OGEN OGEN

Company Profile ↓
$0.54
-57.14% 1Y
Mkt Cap$2.31M
P/E-0.12
P/B0.28
52W High$1.42
52W Low$0.49
Book Value$1.94
EPS (TTM)$-4.56

Company Overview

OGEN (OGEN) is a publicly traded company listed on with a market capitalization of $2.31M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Growth & Price Performance

Stock Price Performance

1 Year:-57.14%
6 Months:-30.77%
3 Months:-15.62%
1 Month:-5.26%
Technical Snapshot Bearish
52-Week Range 5% of range
$0.49 $1.42
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)48.93 · Neutral
Price Performance
1M-5.26%
3M-15.62%
6M-30.77%
1Y-57.14%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 62.0% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.12
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$1.94
Price to Book
0.28
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-
Profit 5Y
-
Revenue (YoY)
-
Earnings (YoY)
-

Profitability & Returns

ROCE
-113.05%
ROE
-118.85%
ROA
-97.76%
Profit Margin
-
Op Margin
-
Gross Margin
-
EPS (Latest Qtr)
$-0.51
EPS (TTM)
$-4.56

Balance Sheet & Liquidity

Debt/Equity
2.75
Quick Ratio
-
Current Ratio
5.64
Debt
$227.35K
Total Assets
$7.49M
Current Assets
$7.49M
Working Capital
$8.28M

Ownership

Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$0
EBITDA
$-9.19M
Free Cash Flow
$-9.25M
Operating Cash Flow
$-9.25M
Shares Outstanding
4.27M
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -------------------------15.08K30.39K86.05K17.02K13.16K7.47K----00000
Cost of Revenue ----------------------------------------
Gross Profit 0-172.30K00-----------------------------------
Operating Expenses -----------------------------------2.03M1.71M3.12M2.50M2.26M
Operating Income -1.87M--2.07M-1.73M-2.03M--1.99M-1.40M-1.92M--2.12M-2.28M-2.76M--3.39M-4.90M-3.92M--5.23M-12.35M-4.51M--5.24M-3.84M-4.39M-4.61M-3.60M-3.91M-2.90M-3.11M-2.09M-2.46M-2.31M-2.44M--2.03M-1.71M-3.12M-2.50M-2.26M
EBITDA ------------------------------------2.02M-1.70M-3.06M-2.42M-2.22M
Interest Expense -----------------------------------199.13K572.31K7.04K7.45K3.73K
Pretax Income ------------------------------------2.22M-2.27M-3.07M-2.42M-2.22M
Tax Provision ----------------------------------00----22.62K
Net Income -1.86M-2.22M-2.06M-312.62K-1.96M-2.67M-1.98M-1.22M-2.07M-1.46M-2.12M-2.28M-2.76M-2.76M-3.33M-4.81M-3.84M-3.60M-5.19M-12.34M-4.50M-4.41M-5.22M-3.82M-4.38M-4.59M-3.59M-3.87M-2.84M-3.05M-2.01M-2.45M-2.31M-2.46M--2.22M-2.27M-3.07M-2.29M-2.20M
Diluted EPS ---------------------------1.85-1.99-1.41-1.51-0.85-0.70-15.27-11.32--3.65-3.10-1.96--0.51
R&D Expense 1.10M-1.22M792.70K924.80K-1.12M605.41K996.48K-1.33M1.27M1.58M-2.41M3.88M3.07M-3.71M11.54M3.50M-3.26M2.47M3.55M3.29M2.59M2.78M1.67M2.01M769.35K663.41K906.78K879.04K-341.54K449.68K930.89K-645.47K

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 1.31M1.44M1.33M1.03M939.93K000----0000
Cost of Revenue ----------------
Gross Profit --453.30K688.88K570.33K000--------
Operating Expenses ------------14.42M20.90M10.56M9.36M
Operating Income -7.90M-7.35M-12.43M-16.21M-5.82M-11.78M-8.54M-6.72M-9.99M-15.88M-26.64M--14.42M-20.90M-10.56M-9.36M
EBITDA -------------14.23M-20.60M-10.54M-9.19M
Interest Expense ------------15.10K30.59K29.83K785.93K
Pretax Income -------------14.29M-20.66M-10.57M-9.98M
Tax Provision ------------000-136.91K
Net Income -7.81M-7.68M-13.09M-16.07M-5.79M-11.71M-7.01M-6.73M-9.91M-15.57M-26.43M--14.29M-20.66M-10.57M-9.84M
Diluted EPS -------------213.30-275.40-47.88-4.56
R&D Expense 2.01M2.45M7.86M9.36M3.07M8.73M4.75M3.54M5.97M12.12M22.11M10.59M10.07M15.49M4.11M2.39M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -1.73M1.27M10.49M16.83M11.13M5.78M4.31M7.21M22.05M19.75M18.68M-14.76M4.97M1.47M10.07M
Current Assets -------------14.29M3.87M1.47M10.07M
Cash & Equivalents 301.59K132.10K171.74K9.93M16.28M10.45M5.08M4.08M6.17M20.21M18.27M17.64M-11.43M3.48M864.84K4.40M
Inventory -----------------
Receivables ------------6.99K0-053.08K
Total Liabilities -3.63M9.45M----------1.75M1.80M1.68M1.79M
Current Liabilities -1.63M9.45M1.26M992.85K796.27K1.05M1.34M898.52K1.17M1.85M1.34M-1.60M1.80M1.68M1.79M
Long Term Debt -----------------
Total Debt -------------624.53K322.51K328.53K227.35K
Total Equity 2.64M-1.90M-8.18M9.23M15.84M10.34M4.73M2.97M6.32M20.88M17.23M16.84M-13.01M3.17M-211.88K8.28M
Shares Outstanding -------------67.49K102.69K419.00K4.27M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -6.45M-5.49M-5.21M---5.19M-7.08M-6.36M-9.08M-13.01M-16.95M--15.23M-7.29M-8.60M-9.25M
Investing Cash Flow -88.08K--11.10K---101.23K1.68M--124.73K-25.21K--43.88K-115.52K-936.28K0-
Financing Cash Flow 6.37M5.53M14.98M---159.95K4.45M8.45M23.25M11.10M16.32M--494.92K283.88K5.98M16.78M
Capital Expenditure -88.08K--11.10K-18.81K-110.67K-102.51K-27.18K--124.73K-25.21K--43.88K-127.52K-1.00M--
Free Cash Flow -6.54M--5.22M---5.29M-7.10M--9.20M-13.04M---15.36M-8.29M-8.60M-9.25M
Net Change in Cash -------------15.84M-7.94M-2.62M7.53M
Share Buybacks -3.75K--------------

Ratios (Annual)

Figures in %.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % --34.0%66.7%60.7%-----------
Operating Margin % -603.8%-508.6%-933.5%-1,570.4%-618.8%-----------
Net Margin % -596.3%-531.6%-982.9%-1,556.7%-616.0%-----------
ROE % 410.9%93.9%-141.8%-101.5%-56.0%-247.5%-236.5%-106.6%-47.5%-90.3%-156.9%--109.8%-652.0%4,987.6%-118.9%
ROCE % -7,849.0%89.8%-134.7%-102.3%-56.3%-249.0%-288.0%-106.4%-47.9%-88.7%-153.7%--109.6%-659.8%4,983.3%-113.1%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for OGEN

Google News Fri, 31 Jul 2026

OGEN|Oragenics Inc|Price:0.530|Chg%:+0.030 - TradingKey

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1mZnZwSnZHdk0tYjlmZU9HeUZfQmpXOFhnNVdONWw5cTNMaEdSQXZRcW9MM1YwcnNWWHNvOHRYdVBTc3VCaWFVcmU2TkVWRTJEN282a0kwYlVYQmJKSmtudE11Z0swbmFERTRlQ1BR?oc=5" target="_blank">OGEN|Oragenics Inc|…

Google News Wed, 24 Jun 2026

Oragenics (OGEN) Sees Minor Pullback as Biotech Stock Holds Above Key Support - Wave Alternation - po-news-eg.net

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNcmpDX1JyNEJ3NDFZMWVtQWpfSk12YnlrMU5Ka2FLUnl6MDRydWw3NzB1Q2ZhM1dZTnpRRmVkNzVqWTlEN2FXNzZhSE8wUHdwNkZTaE4xcUMzT0Fqd3dTWnNxQllUcGpKNVZMX2VvOVRnYV9rUHhlcEtxSVo3TFVqb2stVmpYRDlIVEJkOG…

Google News Wed, 24 Jun 2026

Oragenics (OGEN) Sees Minor Pullback as Biotech Stock Holds Above Key Support - Straddle Setup - dars.gov.et

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNenJvSGxEc3dBNWdyZW9QcXpHRmdKcUpuNVhwZ2VIaVBsUlFkTTZ2b0prVXVoR3hMWndVVC1vWjlDaEpIZlhnR1ZQa3QydDVZQkNWTU5MSEVKN094RC1OU0F6MmpTMWYwMkxhMzJFbUlBODRuR05wZktnV056N2RPNnMwU1Z6TXJpaUdMZ0…

Google News ue, 28 Jul 2026

Oragenics Inc (OGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTFBneklqQUpsR2diQXJWUDhicXgyTU5PZkw0QUx6YnN0MXpNOHYyZHJlNms3RTA0cGw3WHVzMHZQd2kxNGhHY2pISVktazVQQ1NBT3VzQjdxbXlxY2NsdnRlWVZfNEQ?oc=5" target="_blank">Oragenics Inc (OGEN) Revenue Bre…

Google News ue, 01 Jul 2025

Oragenics stock tumbles after announcing $20 million preferred stock offering - Investing.com

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxOMWQwa1ZYTzhkQ21FVl9jOW00cWpIVlczdWc0U3BDTjR2cGdPVERLdVk3TXpxTWl6eVpaWnN2YlhxTjItNTRDOGxuYm9PWFkyeHhQbWFlZE9CSmk2RkZXNkRPV29QdnpGMG00bFRCTUR5bWgzWS1YbnNYUmdfRGpPX3VULU9sTFVvSFpaMV…

Google News Wed, 01 Jul 2026

OGEN Q2 2023 Earnings: Narrower-Than-Expected Loss as Shares Drift Lower - Analyst Consensus Shift - po-news-eg.net

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNMWE1UExSN3ViNWdBcU1SaGpHVkhGNDB4VGJpTlExXzBjVHdtLUQyNXFyaGlHMlRmQ05tN0xIbWVDeGtyWWRDdWhibTlSNDFqSUpuVUxNYTB6b2Y4NS1PdmVKVWo3TzBiQ3Q5SXMyNWk2R0pMZnBXZEFNc21qQVFZeEF0ZlJObXZ4YWRnbl…

OGEN — Frequently Asked Questions

What is the current share price of OGEN?

As of 2026-08-05 17:25 PDT, OGEN trades at $0.54 on NASDAQ/NYSE. Its 52-week range is $0.49 to $1.42.

What is the market capitalisation of OGEN?

OGEN has a market capitalisation of $2.31M on NASDAQ/NYSE.

What is the P/E ratio of OGEN?

OGEN trades at a trailing price-to-earnings (P/E) ratio of -0.12. Its price-to-book (P/B) ratio is 0.28.

What is the return on equity (ROE) of OGEN?

OGEN has a return on equity (ROE) of -118.85%. Its return on capital employed (ROCE) is -113.05%.

Is OGEN a good stock to buy?

This page provides a data-driven analysis of OGEN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space